MedTrace Logo

Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis

NCT01777347 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 778

Last updated 2014-07-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether nebulized hypertonic saline solution reduces the admission rate 48 hours after initial treatment in the emergency department, when compared to normal saline solution (control).

Conditions

  • Acute Viral Bronchiolitis

Interventions

DRUG

3% Saline

Two 4 mL nebulization of 3% saline with 20 minutes interval

DRUG

0.9% Normal Saline

Two 4 mL nebulization of 0.9% normal saline with 20 minutes interval

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Vincent Gajdos, MD, PhD · Assistance Publique Hôpitaux de Paris - Paris Sud Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01777347 on ClinicalTrials.gov